Kala Pharmaceuticals Inc. buy Oppenheimer Holdings Inc.
Start price
01.04.24
/
50%
€7.29
Target price
01.04.25
€13.96
Performance (%)
-12.29%
Price
03.05.24
€6.22
Summary
This prediction is currently active. The prediction for Kala Pharmaceuticals Inc. disappoints with a performance of -12.29%. This prediction currently runs until 01.04.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Kala Pharmaceuticals Inc. | 5.913% | 5.913% |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Kala Pharmaceuticals diskutieren
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Ratings data for KALA provided by MarketBeat